Guidelines for the safe preparation of sterile compounds: Results of the ISMP sterile preparation compounding safety summit of October 2011

Hospital Pharmacy

Volumn 48, Issue 4, 2013, Pages 282-294

  Rich, Darryl S ^a   Fricker, Matthew P ^a   Cohen, Michael R ^a   Levine, Stuart R ^b  

^a INSTITUTE FOR SAFE MEDICATION PRACTICES   (United States)

^b NONE

Author keywords

compounding; guidelines; organizations; patient safety; pharmacy; quality assurance; sterile products

Indexed keywords

ARTICLE; DRUG FORMULATION; DRUG QUALITY; DRUG SAFETY; DRUG STERILITY; DRUG SYNTHESIS; HUMAN; PHARMACY; PRACTICE GUIDELINE;

EID: 84876035528     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4804-282     Document Type: Article

References (27)

1. Mackel DC, Maki DG, Anderson RI, et al. Nationwide epidemic of septicemia caused by contaminated intravenous products: mechanisms of intrinsic contamination. J Clin Microbiol. 1975; 2:436-497.
2. Hughes CF, Grant AF, Lick BD, et al. Cardioplegic solution: a contamination crisis. J Thorac Cardiovasc Surg. 1986; 91:296-302. (Pubitemid 16164443)
3. Sterile compounding tragedy is a symptom of a broken system on many levels. ISMP Medication Safety Alert. 2012; 17 (21):1-4.
4. McVeigh K. Meningitis outbreak: Massachusetts agencies ''failed to enforce regulations.'' The Guardian. October 10, 2012. http://m.guardian.co.uk/ society/2012/oct/13/meningitisoutbreak-massachusetts-regulations? cat5society&type5article. Accessed October 23, 2012.
5. Pharmaceutical compounding - sterile preparations (general information chapter 797). In: United States Pharmacopeia and National Formulary (USP 35Rev/NF 30Ed). Rockville, MD: United States Pharmacopeia Convention; 2012:350-387. http://www.usp.org/sites/default/files/usp-pdf/EN/hottopics/c797. pdf. Accessed November 7, 2012.
6. Clinical IQ. 797 State survey. www.clinicaliq.com/797- state-survey. Accessed October 23, 2012.
7. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration -2011. Am J Health Syst Pharm. 2012; 69:768-785.
8. Douglass K, Kastango ES, Cantor P. The 2012 USP, 797. compliance survey: measuring progress. Pharm Purchasing Products. 2012; 8 (10):S4-24.
9. Smith M. Meningitis: pharmacy in outbreak violated license. MedPage Today. www.medpagetoday.com/Neurology/GeneralNeurology/35276. Accessed October 12, 2012.
10. Centers of Disease Control and Prevention. Multistate fungal meningitis outbreak - current case count. http://www.cdc.gov/hai/outbreaks/meningitis-map- large.html. Accessed February 11, 2013.
11. State of pharmacy compounding 2009: survey findings. Pharm Purchasing Products. 2009; 6 (4):4-20.
12. Flynn EA, Pearson RE, Barker K. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health Syst Pharm. 1997; 54 (8):904-912. (Pubitemid 27183619)
13. Criminal prosecution of human error will likely have dangerous long-term consequences. ISMP Medication Safety Alert. 2007; 12 (5):1-2.
14. Failed check system for chemotherapy leads to pharmacist's no contest plea for involuntary manslaughter. ISMP Medication Safety Alert. 2009; 14 (8):1-2.
15. Fatal 1,000-fold overdoses can occur, particularly to neonates, by transposing mcg and mg. ISMP Medication Safety Alert. 2007; 12 (18):1-4.
16. Deaths from intravenous colchicine resulting from a compounding pharmacy error -Oregon and Washington, 2007. MMWR Weekly. 2007; 56:1050-1052.
17. Another tragic parenteral nutrition compounding error. ISMP Medication Safety Alert. 2011; 16 (8):1-3.
18. Unfortunately, this time it wasn't the equipment. ISMP Medication Safety Alert. 2005; 10 (20):1-2.
19. Unread labels. ISMP Medication Safety Alert. 2008; 13 (18):1-2.
20. Safe practices in pharmacy sterile compounding errors. ISMP Medication Safety Alert. 2011; 16 (11):1-4.
21. Results of ISMP survey on high-alert medications. ISMP Medication Safety Alert. 2012; 17 (3):1-4.
22. Medication management standard MM.02.01.01 - Element of Performance. In: 2012 Comprehensive Accreditation Manual for Hospitals. Update Oakbrook Terrace, IL: The Joint Commission; 2011:MM-8.
23. Phillips MS. Standardizing i.v. infusion concentrations: National survey results. Am J Health Syst Pharm. 2011; 68: 2176-2182.
24. Churchill W. Use of Automation and robotic technology to improve the process for preparing compounded sterile products. ASHP Advantage Webinar. October 25, 2010. http://www.ashpadvantagemedia.com/ivautomation/webinarhandout. pdf. Accessed October 23, 2012.
25. O'Neil BC, Worden JC, Couldry RJ. Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area. Am J Health Syst Pharm. 2009; 66:1211-1217.
26. Hellums M, Alverson SP, Monk-Tutor MR. Instruction on compounded sterile preparations at U.S. schools of pharmacy. Am J Health Syst Pharm. 2007; 64:2267-2274. (Pubitemid 350086191)
27. Rinehart JR, Chan D, Cunningham M, et al. ASHP guidelines on outsourcing sterile compounding services. Am J Health Syst Pharm. 2010; 67 (9):757-765.